| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |